Skip to main content
OpenTrials

Clinical trial condition

Hereditary Sensory and Autonomic Neuropathies

Explore clinical trials studying Hereditary Sensory and Autonomic Neuropathies. Study availability and eligibility vary by location and protocol.

120 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Sensory and Autonomic Neuropathies trial results

Active, not recruiting

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

NCT04980872

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital Abnormalities, +15 more
Locations
  • Children's Healthcare of Atlanta - Egleston Hospital ( Site 0107) Atlanta, Georgia, United States
  • Boston Children's Hospital ( Site 0089) Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center-Hematology ( Site 0102) Cincinnati, Ohio, United States
  • Texas Children's Hospital ( Site 0104) Houston, Texas, United States
View Trial Details
Active, not recruiting

A Study of NDI 1150-101 in Patients With Solid Tumors

NCT05128487

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 19 locations
View Trial Details
Completed

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

NCT06433219

Conditions
Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Francisco - UCSF Medical Center San Francisco, California, United States
  • Centricity Research Cancer Center - DBA CRRI John B. Amos Cancer Center Research Columbus, Georgia, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross - Carolyn J. Czerkies Pavilion Chicago, Illinois, United States
View all 84 locations
View Trial Details
Completed

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

NCT05882734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • UCLA Hematology and Oncology - Santa Monica Santa Monica, California, United States
  • UPMC Cancer Center Pittsburgh, Pennsylvania, United States
  • Tennessee Cancer Specialists - Biomedical Research Knoxville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 54 locations
View Trial Details
Completed

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

NCT04997902

Conditions
Carcinoma, Carcinoma, Squamous Cell, Congenital Abnormalities, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Lake Nona DDU (Florida Cancer Specialists) Orlando, Florida, United States
  • University of Maryland School of Medicine (Marlene and Stewart Greenebaum Comprehensive Cancer Center) Baltimore, Maryland, United States
  • Johns Hopkins University School of Medicine (Sidney Kimmel Comprehensive Cancer Center) Baltimore, Maryland, United States
View Trial Details

Related conditions